A Prospective Non-interventional Study in Patients With Chronic Obstructive Pulmonary Disease That Evolve to Fixed Long-acting Muscarinic Antagonist/Long-acting beta2-agonist/Inhaled Corticosteroid Triple Therapy, Trimbow
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms TRIVOLVE
- Sponsors Chiesi
- 12 Sep 2018 Planned End Date changed from 1 Aug 2019 to 1 Jun 2020.
- 12 Sep 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Mar 2020.
- 12 Sep 2018 Status changed from not yet recruiting to recruiting.